Evidence map›Paper›PMID 30664879›Full record

Trial reportGastroenterology2019

Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis.

Jasmohan S Bajaj, Andrew Fagan, Edith A Gavis, Zain Kassam, Masoumeh Sikaroodi, Patrick M Gillevet

Registry-linked trialAbstract readClinical Trial, Phase IRandomized Controlled Trial
In one paragraph

Trial report in Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07490054 (An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of Intestinal Microbiota Transplantation In Patients With Chronic Heart Failure), which is not on this map. Cited by 97 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07490054 phase1recruitingnot on this mapstarted 2025, after this paper: background citation

An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of Intestinal Microbiota Transplantation In Patients With Chronic Heart Failure

TypeinterventionalSponsorMelana Yuzefpolskaya, MDRan2025 to 2027Enrolled40ConditionsChronic Heart FailureArmsMTP-101-C encapsulated Microbiota, Vancomycin, Neomycin
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Effect of a specificWorld journal of hepatology · 2022
    Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  19. Review
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Jasmohan S BajajDivision of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia. Electronic address: jasmohan.bajaj@vcuhealth.org.
Andrew FaganDivision of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Edith A GavisDivision of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Zain KassamFinch Therapeutics Group, Somerville, Massachusetts.
Masoumeh SikaroodiMicrobiome Analysis Center, George Mason University, Manassas, Virginia.
Patrick M GillevetMicrobiome Analysis Center, George Mason University, Manassas, Virginia.

Funding

Research Supplement to Promote Diversity in Health Related ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2018 to 2022
$19.1M
Modulation of Gut-Brain Axis Using Fecal Microbiome Transplant Capsules in CirrhosisR21TR002024 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2017 to 2018
$414k
Fecal Microbiota Transplant in Veterans with CirrhosisI01CX001076 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI BAJAJ, JASMOHAN S · 2015 to 2024
–
CSRD VA I01 CX001076NCATS NIH HHS R21 TR002024NCATS NIH HHS UL1 TR002649
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CognitionFecal Microbiota TransplantationHospitalizationAnti-Bacterial AgentsFollow-Up StudiesGastrointestinal AgentsGastrointestinal MicrobiomeHepatic EncephalopathyHumansLactuloseLiver CirrhosisPatient SelectionRifaximinStroop TestTime FactorsAnti-Bacterial AgentsGastrointestinal AgentsLactuloseRifaximin

Identifiers

PMID30664879
PMCPMC6475479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.